Want to see HK:9995 full AI Analyst Report?
RemeGen Co. Ltd. Class H (9995) Ratios
RemeGen Co. Ltd. Class H Ratios
HK:9995's free cash flow for Q3 2026 was $-111.58M. For the 2026 fiscal year, HK:9995's free cash flow was decreased by $-34.72M and operating cash flow was $-76.86M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.43 | 1.05 | 1.96 | 3.60 | 3.73 |
| Quick Ratio | 1.19 | 0.75 | 1.31 | 3.01 | 3.28 |
| Cash Ratio | 0.43 | 0.35 | 0.62 | 2.32 | 2.85 |
| Solvency Ratio | 0.28 | -0.35 | -0.61 | -0.78 | 0.56 |
| Operating Cash Flow Ratio | 0.02 | -0.51 | -1.32 | -1.42 | 0.43 |
| Short-Term Operating Cash Flow Coverage | 0.04 | -0.81 | -5.24 | 0.00 | -0.66 |
| Net Current Asset Value | $ 344.34M | $ -1.22B | $ 137.96M | $ 2.17B | $ 1.59B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.49 | 0.23 | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.61 | 1.34 | 0.37 | 0.03 | 0.03 |
| Debt-to-Capital Ratio | 0.38 | 0.57 | 0.27 | 0.03 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.38 | 0.20 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.01 | 2.77 | 1.61 | 1.21 | 1.21 |
| Debt Service Coverage Ratio | 0.29 | -0.83 | -4.03 | -119.09 | -1.02 |
| Interest Coverage Ratio | 2.28 | -20.11 | -65.03 | -156.00 | 30.59 |
| Debt to Market Cap | 0.06 | 0.35 | 0.06 | 0.00 | -0.01 |
| Interest Debt Per Share | 4.14 | 5.10 | 2.38 | 0.32 | 0.22 |
| Net Debt to EBITDA | 2.33 | -1.60 | -0.44 | 2.36 | -4.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 86.87% | 79.81% | 76.48% | 64.84% | 95.28% |
| EBIT Margin | 3.75% | -82.98% | -138.29% | -129.21% | 19.78% |
| EBITDA Margin | 13.32% | -69.53% | -115.96% | -104.94% | 28.24% |
| Operating Profit Margin | 4.82% | -84.79% | -139.53% | -137.29% | 11.44% |
| Pretax Profit Margin | 21.92% | -85.53% | -140.43% | -130.09% | 19.40% |
| Net Profit Margin | 21.89% | -85.53% | -140.43% | -129.96% | 19.40% |
| Continuous Operations Profit Margin | 21.89% | -85.53% | -140.43% | -130.09% | 19.40% |
| Net Income Per EBT | 99.89% | 100.00% | 100.00% | 99.90% | 100.00% |
| EBT Per EBIT | 454.38% | 100.87% | 100.65% | 94.76% | 169.65% |
| Return on Assets (ROA) | 9.79% | -26.70% | -27.34% | -16.57% | 6.64% |
| Return on Equity (ROE) | 19.66% | -73.93% | -43.97% | -20.04% | 8.02% |
| Return on Capital Employed (ROCE) | 3.50% | -43.84% | -34.20% | -20.55% | 4.60% |
| Return on Invested Capital (ROIC) | 2.64% | -30.63% | -31.71% | -20.29% | 5.09% |
| Return on Tangible Assets | 10.00% | -27.42% | -28.07% | -16.73% | 6.73% |
| Earnings Yield | 2.00% | -20.19% | -8.25% | -3.68% | 0.90% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.02 | 2.75 | 2.56 | 2.57 | 201.97 |
| Payables Turnover | 1.49 | 2.14 | 1.82 | 1.22 | 0.42 |
| Inventory Turnover | 0.64 | 0.53 | 0.34 | 0.52 | 0.24 |
| Fixed Asset Turnover | 1.09 | 0.61 | 0.35 | 0.29 | 0.82 |
| Asset Turnover | 0.45 | 0.31 | 0.19 | 0.13 | 0.34 |
| Working Capital Turnover Ratio | 4.96 | 2.85 | 0.63 | 0.38 | 0.67 |
| Cash Conversion Cycle | 413.17 | 655.89 | 1010.96 | 549.18 | 659.69 |
| Days of Sales Outstanding | 90.81 | 132.56 | 142.60 | 142.21 | 1.81 |
| Days of Inventory Outstanding | 567.67 | 694.13 | 1069.26 | 706.74 | 1523.38 |
| Days of Payables Outstanding | 245.31 | 170.80 | 200.90 | 299.76 | 865.50 |
| Operating Cycle | 658.48 | 826.70 | 1211.86 | 848.94 | 1525.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.10 | -2.07 | -2.78 | -2.38 | 0.54 |
| Free Cash Flow Per Share | -0.26 | -2.56 | -4.36 | -3.81 | -0.73 |
| Dividend Paid and CapEx Coverage Ratio | 0.28 | -3.33 | -1.73 | -1.67 | 0.43 |
| Capital Expenditure Coverage Ratio | 0.28 | -4.20 | -1.76 | -1.67 | 0.43 |
| Operating Cash Flow Coverage Ratio | 0.02 | -0.42 | -1.19 | -7.66 | 2.57 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.65 | -1.40 | -1.65 | 0.19 |
| Free Cash Flow Yield | -0.39% | -18.97% | -12.86% | -7.46% | -1.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 50.13 | -4.95 | -12.12 | -27.16 | 111.72 |
| Price-to-Sales (P/S) Ratio | 10.96 | 4.24 | 17.02 | 35.30 | 21.68 |
| Price-to-Book (P/B) Ratio | 9.84 | 3.66 | 5.33 | 5.44 | 8.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -253.57 | -5.27 | -7.78 | -13.41 | -87.26 |
| Price-to-Operating Cash Flow Ratio | 648.81 | -6.53 | -12.19 | -21.45 | 117.08 |
| Price-to-Earnings Growth (PEG) Ratio | -0.34 | 1.98 | -0.25 | 0.06 | -0.84 |
| Enterprise Value Multiple | 84.60 | -7.69 | -15.12 | -31.28 | 72.65 |
| Enterprise Value | 36.53B | 9.19B | 18.87B | 25.20B | 29.21B |
| EV to EBITDA | 84.60 | -7.69 | -15.12 | -31.28 | 72.65 |
| EV to Sales | 11.27 | 5.35 | 17.53 | 32.82 | 20.51 |
| EV to Free Cash Flow | -260.74 | -6.66 | -8.01 | -12.47 | -82.58 |
| EV to Operating Cash Flow | 667.16 | -8.24 | -12.56 | -19.94 | 110.80 |
| Tangible Book Value Per Share | 6.30 | 3.43 | 6.10 | 9.29 | 6.96 |
| Shareholders’ Equity Per Share | 6.57 | 3.69 | 6.37 | 9.39 | 7.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 5.90 | 3.19 | 1.99 | 1.45 | 2.92 |
| Net Income Per Share | 1.29 | -2.73 | -2.80 | -1.88 | 0.57 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 5.84 | 1.03 | 1.02 | 1.01 | 0.98 |
| Research & Development to Revenue | 0.33 | 0.91 | 1.21 | 1.28 | 0.50 |
| SG&A to Revenue | 0.46 | 0.75 | 0.29 | 0.35 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.04 | 0.08 | 0.07 | 0.01 |
| Income Quality | 0.08 | 0.76 | 0.99 | 1.27 | 0.95 |
Currency in CNY